677. Activity of Novel β-Lactamase Inhibitor QPX7728 Combined with β-Lactam Agents When Tested Against Carbapenem-Resistant Enterobacteriaceae (CRE) Isolates

BACKGROUND: CREs have been described worldwide and these isolates are often multidrug resistant with few therapeutic options remaining active against them. New β-lactam (BL)/β-lactamase inhibitor (BLI) combinations recently approved are active against KPC and some OXA-48 producers, but not against i...

Descripción completa

Detalles Bibliográficos
Autores principales: Castanheira, Mariana, Lindley, Jill, Huynh, Holly, Mendes, Rodrigo E, Lomovskaya, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811269/
http://dx.doi.org/10.1093/ofid/ofz360.745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811269/
http://dx.doi.org/10.1093/ofid/ofz360.745

Ejemplares similares